Biophytis Deploys Its Partnership Strategy and Signs Two Contracts With Local Agents in Asia

AccesswireJul 22 14:30

Biophytis Obtains IND Approval From the FDA to Start Its Phase 2 OBA Study in Obesity

AccesswireJul 11 14:40

Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris

AccesswireJul 1 13:20

6-K: Report of foreign private issuer (related to financial reporting)

SECJun 27 01:48 · Announcements

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million

AccesswireJun 20 13:20

Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by Its Service Provider Seqens

AccesswireJun 12 16:25